Cargando…

Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs

Pancreatic ductal adenocarcinoma (PDAC) is characterised by a pro-inflammatory stroma and multi-faceted microenvironment that promotes and maintains tumorigenesis. However, the models used to test new and emerging therapies for PDAC have not increased in complexity to keep pace with our understandin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brumskill, Sarah, Barrera, Lawrence N., Calcraft, Peter, Phillips, Caroline, Costello, Eithne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905179/ https://www.ncbi.nlm.nih.gov/pubmed/34865180 http://dx.doi.org/10.1007/s13105-021-00857-2

Ejemplares similares

The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis
por: Barrera, Lawrence N., et al.
Publicado: (2022)

Where the metabolome meets the microbiome for pancreatic cancer detection
por: Oldfield, Lucy, et al.
Publicado: (2023)

The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
por: Evans, Anthony, et al.
Publicado: (2012)

Recent advances in understanding pancreatic cancer
por: Stott, Martyn C, et al.
Publicado: (2022)

Evaluation of the Triage TOX Drug Screen Assay for Detection of 11 Drugs of Abuse and Therapeutic Drugs
por: Bang, Hae In, et al.
Publicado: (2017)

Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
por: Zhang, Lulin, et al.
Publicado: (2018)

A drug screening assay on cancer cells chronically adapted to acidosis
por: Pellegrini, Paola, et al.
Publicado: (2018)

High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids
por: Choo, Nicholas, et al.
Publicado: (2021)

Investigation of Drug Cocktail Effects on Cancer Cell-Spheroids Using a Microfluidic Drug-Screening Assay
por: Au Ieong, Ka I., et al.
Publicado: (2017)

Role of cytokines in the interplay between cancer cells and stroma-associated monocytes
por: Nedjadi, Taoufik, et al.
Publicado: (2014)

A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening
por: Stackhouse, Christian T., et al.
Publicado: (2019)

Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
por: Villaverde, Antonio, et al.
Publicado: (2012)

Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
por: Lee, Pei-Jung, et al.
Publicado: (2021)

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
por: Shaw, Victoria E, et al.
Publicado: (2014)

CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
por: Szlachta, Karol, et al.
Publicado: (2018)

Drug metabolism and pancreatic cancer
por: Flores, John Paul E., et al.
Publicado: (2017)

Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
por: Rashid, Md Abdur, et al.
Publicado: (2022)

S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes
por: Nedjadi, Taoufik, et al.
Publicado: (2018)

Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
por: Larsson, Peter, et al.
Publicado: (2020)

The identification of candidate effective combination regimens for pancreatic cancer using the histoculture drug response assay
por: Jun, Eunsung, et al.
Publicado: (2020)

UHRF1 regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis
por: Abu‐Alainin, Wafa, et al.
Publicado: (2015)

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
por: Pan, Chun‐Hao, et al.
Publicado: (2020)

Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts
por: Noel, Pawan, et al.
Publicado: (2017)

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
por: Vaish, Utpreksha, et al.
Publicado: (2021)

Screening of Therapeutic Targets for Pancreatic Cancer by Bioinformatics Methods
por: Xiao, Xiaojie, et al.
Publicado: (2023)

The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?
por: Brewer, Gabrielle, et al.
Publicado: (2021)

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
por: Yang, Dan, et al.
Publicado: (2020)

Novel therapeutic modalities and drug delivery in pancreatic cancer – an ongoing search for improved efficacy
por: Zhang, Yuqing, et al.
Publicado: (2012)

CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
por: Malik, Shivani, et al.
Publicado: (2021)

Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach
por: Hussain, Naushair, et al.
Publicado: (2022)

Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
por: Hirt, Christian K., et al.
Publicado: (2022)

Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022)

Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma
por: Armstrong, Andrew, et al.
Publicado: (2021)

An Assay Suitable for High Throughput Screening of Anti-Influenza Drugs
por: Mao, Lili, et al.
Publicado: (2013)

RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
por: Tang, Zhichao, et al.
Publicado: (2021)

A fluorescence-based assay for Trichomonas vaginalis drug screening
por: Chen, Qianqian, et al.
Publicado: (2023)

Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation
por: Coleman, David T., et al.
Publicado: (2016)

Tracing the Origin of Fibroblasts in Pancreatic Cancer
por: Biffi, Giulia
Publicado: (2020)

Functional diversity of cancer‐associated fibroblasts in modulating drug resistance
por: Bu, Luke, et al.
Publicado: (2020)

Understanding drugs in breast cancer through drug sensitivity screening
por: Uhr, Katharina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_irocg5s8qmbjmucn8cneugr4d3